INBLAYDRA
Live / Allowed — Publication / registration review complete (as of 05 Nov 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 17 Jun 2026 filing date already counts against anyone who files later.
Record
- Serial number
- 99890658
- Mark type
- Word mark
- Filed
- 17 Jun 2026
- Published for opposition
- 24 Nov 2026
- Attorney of record
- Danielle Rivera
Goods and services
- Class 005 — Pharmaceuticals: Human pharmaceutical preparations for the prevention and treatment of viral diseases, auto-immune and inflammatory diseases, alloimmune diseases, cardiovascular and pulmonary diseases, central nervous system diseases, peripheral neurological system diseases, pain, dermatologic diseases, gastro-intestinal diseases, infectious-related diseases, metabolic diseases, oncologic diseases, ophthalmic diseases, respiratory diseases, hematological diseases, urological diseases, maternal fetal disorders
- Class 010 — Medical apparatus: Medical apparatus for introducing pharmaceutical preparations into the human body; implantable medical device for introducing pharmaceutical preparations into the human body; implantable drug delivery device
Owner
- Johnson & Johnson, New Brunswick, NJ, US
Prosecution history
- 28 Oct 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 27 Oct 2026 — ASSIGNED TO EXAMINER
- 26 Oct 2026 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 17 Jun 2026 — APPLICATION FILING RECEIPT MAILED
- 17 Jun 2026 — NEW APPLICATION ENTERED